NCT04605458View on ClinicalTrials.gov

Contingency Management to Promote Smoking Abstinence in Cancer Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

July 10, 2025

Study Completion Date

February 28, 2026

Conditions
Smoking Cessation
Interventions
COMBINATION_PRODUCT

Contingency Management

Participants will receive 3-6 counseling sessions, nicotine patches \& lozenges, and monetary payment delivered contingent on abstinence verified by CO breath test.

COMBINATION_PRODUCT

Standard Care

Participants will receive 3-6 counseling sessions, nicotine patches \& lozenges, and CO breath test monitoring.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Medical University of South Carolina

OTHER